Methods for modulating RNA processing
NEAR constructs address the limitations of CRISPR systems by precisely modulating RNA processing events, enhancing safety and efficacy in identifying and analyzing RNA targets for conditions like neurodegenerative diseases and cancers.
Patent Information
- Application Number
- PCT/US2025/013954
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-02-02
- Filing Date
- 2025-01-31
- Publication Date
- 2025-08-07
AI Technical Summary
Current methods for targeting RNA processing events, such as CRISPR systems, pose risks of altering DNA sequences, have PAM requirements, and can trigger immunogenic responses, limiting their effectiveness and safety in modulating RNA processing.
Utilization of nuclear expressed antisense RNA (NEAR) constructs to modulate RNA processing events by recruiting mammalian nuclear ribonucleoproteins, allowing precise targeting and analysis of RNA processing targets in cells.
NEAR constructs enable efficient and specific modulation of RNA processing events, such as alternative splicing and polyadenylation, with reduced off-target effects and immunogenicity, facilitating the identification and analysis of RNA processing targets associated with conditions like neurodegenerative diseases and cancers.